Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB06147ApprovedVet approvedWithdrawnSmall molecule
Sulfathiazole is a short-acting sulfa drug. It used to be a common oral and topical antimicrobial until less toxic alternatives were discovered. It is still occasionally used, sometimes in combination... Except for those formulated for vaginal use, the FDA withdrew its approval for the use of all drug products containing sulfathiazole.
- Mechanism
- Curator reviewed
Pharmacologically active on Dihydropteroate synthase and dihydropteroate synthase
- Primary indication
- Sulfathiazole is effective against a wide range of gram positive and gram negative pathogenic microorganisms.Curator reviewed · 12 structured indications
- Formula / weight
- C9H9N3O2S2 · 255.317 g/mol (avg)
- First approval
- United States, 1983
- Also known as
- 2-Sulfanilamidothiazole · 2-Sulfonamidothiazole · Sulfanilamidothiazole · Sulphathiazole
Resolves to
Structure
InChIKey
JNMRHUJNCSQMMB-UHFFFAOYSA-NSMILESNC1=CC=C(C=C1)S(=O)(=O)NC1=NC=CS1What you can answer from here — as of August 30, 2026
2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
Which drugs share a target with Sulfathiazole, and which of those have an active Phase 3 trial?